MYC and neoplasm: The GSVA results showed that the high-risk group was mainly enriched in cell cycle-related pathways, such as E2F targets, G2M checkpoint, and MYC targets, whose activation may promote tumor progression, while the low-risk group was mainly enriched in metabolism-related pathways, such as fatty acid metabolism and bile acid metabolism.